Home » Kate Watkins

Kate Watkins

Analyst

Kate Watkins is an Analyst at CBPartners.

Connect with Kate Watkins

kate.watkins@cbpartners.com

LinkedIn

Published Articles

AI-Based Software Paige Prostate is Granted FDA Approval Through the De Novo Regulatory Pathway

CBPartners' Digital Therapeutics & Health Technology Expertise Team summarizes the approval of the first AI-based software designed to identify areas of concern on a prostate biopsy image.

Verily to Acquire SignalPath, Expanding the Company’s Clinical Research Capabilities

Verily recently announced its first major acquisition, a software platform known as SignalPath. The acquisition would fold SignalPath into Baseline, Verily’s clinical research platform.

KAISER Integrates DTx Into the Behavioral Health Treatment Paradigm at No Extra Cost After a Clinician Referral

KAISER’s recent systemic integration of digital health therapeutics (DTx) into the treatment paradigm for behavioral health concerns is a step towards modernizing healthcare and represents a very structured approach to real-world data generation.

FDA Launches the Digital Health Center of Excellence